Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.
D020811:Biomedical Technology; D001853:Bone Marrow; D001943:Breast Neoplasms; D002961:Civil Rights; D003256:Community Participation; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003695:Delivery of Health Care; D003709:Democracy; D030881:Disclosure; D004467:Economics; D004989:Ethics; D004991:Ethics, Institutional; D006130:Growth Disorders; D017408:Guidelines as Topic; D015276:Health Care Rationing; D006728:Hormones; D006801:Humans; D007221:Industry; D007348:Insurance, Health; D007349:Insurance, Health, Reimbursement; D007603:Jurisprudence; D008329:Managed Care Programs; D009313:National Health Programs; D017008:Negotiating; D018579:Patient Selection; D017149:Private Sector; D011640:Public Policy; D017150:Public Sector; D012106:Research; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012935:Social Justice; D012941:Social Responsibility; D012946:Social Welfare; D013673:Technology Assessment, Biomedical; D036302:Therapeutic Human Experimentation; D035703:Therapies, Investigational; D016378:Tissue Transplantation; D014481:United States
Analytical Approach; Health Care and Public Health